Skip to content

Scholar Rock SRRK Restricted Cash

Restricted Cash at other companies

Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$416K
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$601K+29.5%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$288K+28.0%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$17K
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Roivant Sciences logo
Roivant SciencesROIV

Other financials

Income statement

See full
Revenue-
Operating income-$102.0M-32.3%
Net income-$105.5M-41.2%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%
Total assets$535.3M+31.3%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$5.67B+85.5%
Enterprise value$5.45B+82.6%
P/S170.9×

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashNoncurrent.

The official record: Scholar Rock’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's restricted cash?
Scholar Rock (SRRK) reported restricted cash of $3.81M in Q1 2026.
How has Scholar Rock's restricted cash changed year-over-year?
Scholar Rock's restricted cash increased by 58.2% year-over-year, from $2.41M to $3.81M.
What is the long-term trend for Scholar Rock's restricted cash?
Over 5 years (2020 to 2025), Scholar Rock's restricted cash has grown at a 8.8% compound annual growth rate (CAGR), from $2.5M to $3.81M.
What does restricted cash mean?
Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.